Sulfuric Acid

Sulfuric Acid

SCHEMBL78884

CCN(CC)CC.O=S(=O)(O)O

nearest known ligand 0.46

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

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

The experimentally established mechanism targets of Sulfuric Acid. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CHRM2 known ✓ P08172 1/20 0.33
CHRM1 known ✓ P11229 1/20 0.33
CHRM3 known ✓ P20309 1/20 0.33
NPSR1 Q6W5P4 2/20 0.46
CA5A P35218 1/20 0.43
CA5B Q9Y2D0 1/20 0.43
CHRM4 P08173 1/20 0.33
CHRM5 P08912 1/20 0.33
TP53 P04637 1/20 0.33
ALDH1A1 P00352 3/20 0.32
MEN1 O00255 2/20 0.32
CYP2C9 P11712 2/20 0.32
HPGD P15428 2/20 0.32
KMT2A Q03164 2/20 0.32
L3MBTL1 Q9Y468 2/20 0.32
CYP2C19 P33261 2/20 0.32
HSP90AA1 P07900 1/20 0.32
CA1 P00915 1/20 0.32
PAOX Q6QHF9 1/20 0.31
KDM4E B2RXH2 3/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Sulfuric Acid SCHEMBL16059228 1.00 NPSR1 (0.46) NPSR1CA5ACA5BCHRM2CHRM4
Sulfuric Acid SCHEMBL11137352 1.00 NPSR1 (0.46) NPSR1CA5ACA5BCHRM2CHRM4
Sulfuric Acid SCHEMBL27883463 1.00 NPSR1 (0.46) NPSR1CA5ACA5BCHRM2CHRM4
Sulfuric Acid SCHEMBL1334876 1.00 NPSR1 (0.46) NPSR1CA5ACA5BCHRM2CHRM4
Sulfuric Acid SCHEMBL11137355 1.00 NPSR1 (0.46) NPSR1CA5ACA5BCHRM2CHRM4
Sulfuric Acid SCHEMBL29289482 1.00 NPSR1 (0.46) NPSR1CA5ACA5BCHRM2CHRM4
Sulfuric Acid SCHEMBL28627679 0.97 NPSR1 (0.45) NPSR1CA5ACA5BCHRM2CHRM4
Sulfuric Acid SCHEMBL11513250 0.97 NPSR1 (0.45) NPSR1CA5ACA5BCHRM2CHRM4
Sulfuric Acid SCHEMBL28432960 0.97 NPSR1 (0.45) NPSR1CA5ACA5BCHRM2CHRM4
Sulfuric Acid SCHEMBL28536745 0.97 NPSR1 (0.45) NPSR1CA5ACA5BCHRM2CHRM4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1054 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4705547-A1 PROCESS FOR THE PREPARATION OF 1,1,4,4-TETRAALKYLOXY-2-BUTENE DSM IP Assets B.V. (NL) 2026-03-11 EP claimed
WO-2025262501-A2 METHOD FOR MANUFACTURING POLYVINYL CHLORIDE PRODUCTS UNILIN, BV (BE) 2025-12-26 WO claimed
US-20250353823-A1 PROCESS FOR THE PREPARATION OF ALKOXYLATED 2,5-DIHYDROFURAN DSM IP ASSETS BV (NL) 2025-11-20 US claimed
US-20250347033-A1 METHOD FOR MAKING FIBRES IMPERIAL COLLEGE INNOVATIONS LTD (GB) 2025-11-13 US claimed
EP-4638574-A1 METHOD FOR MANUFACTURING A POLYVINYL CHLORIDE PRODUCTS Unilin, BV (BE) 2025-10-29 EP claimed
US-20250283255-A1 METHOD FOR MAKING FIBRES IMPERIAL COLLEGE INNOVATIONS LIMITED (GB) 2025-09-11 US claimed
EP-3275039-B1 ELECTROLYTES AND METAL HYDRIDE BATTERIES BASF CORP (US) 2025-08-27 EP claimed
EP-3822259-B1 METHOD FOR SYNTHESIZING VALSARTAN ZHEJIANG HUAHAI PHARM CO LTD (CN) 2025-08-27 EP claimed
EP-4590410-A1 METHOD FOR RECYCLING POLYVINYL CHLORIDE PRODUCTS Unilin, BV (BE) 2025-07-30 EP claimed
CN-120022522-A Drug-loaded microneedle, drug-loaded microneedle patch and electrically-controlled drug release microneedle system 成都邦迈医创科技有限公司 2025-05-23 CN claimed
WO-1982000586-A1 NOVEL RUTIN NONA-AND DECA(H-)SULFATE SALTS,METHODS OF PREPARING NOVEL SALTS,AND USE OF NOVEL SALTS AS COMPLEMENT INHIBITORS AMERICAN CYANAMID CO (US) 1982-03-04 WO claimed
US-4177043-A TREATMENT OF FLY ASH WITH AMMONIUM SULFATE AND TRIETHYLAMINE SULFATE NALCO CHEMICAL COMPANY (US) 1979-12-04 US claimed
US-4076949-A REACTING ALCOHOL WITH CARBON MONOXIDE AND OXYGEN, CATALYSIS ATLANTIC RICHFIELD COMPANY (US) 1978-02-28 US claimed
US-4069388-A Preparation of oxalate esters from carbon monoxide and an alkoxycycloalkene ATLANTIC RICHFIELD COMPANY (US) 1978-01-17 US claimed
US-4065490-A Process for the preparation of oxalate esters from carbon monoxide and an enol ether ATLANTIC RICHFIELD COMPANY (US) 1977-12-27 US claimed
US-4041067-A AS CATALYST A PALLADIUM, PLATINUM, RHODIUM, CADMIUM, COBALT, ZINC OR COPPER SALT WITH AN AMINE AND AN ALCOHOL ATLANTIC RICHFIELD COMPANY (US) 1977-08-09 US claimed
US-4041068-A AS CATALYST A PALLADIUM, PLATINUM OR RHODIUM SALT WITH AN AMINE AND AN ALCOHOL ATLANTIC RICHFIELD COMPANY (US) 1977-08-09 US claimed
US-4005131-A METAL SALT CATALYST, AMINE BASE ATLANTIC RICHFIELD COMPANY (US) 1977-01-25 US claimed
US-4005129-A OXALATE ESTERS ATLANTIC RICHFIELD COMPANY (US) 1977-01-25 US claimed
US-3992436-A Synthesis of oxalate esters from carbon monoxide and carboxylic ortho esters ATLANTIC RICHFIELD COMPANY (US) 1976-11-16 US claimed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20250353823-A1 PROCESS FOR THE PREPARATION OF ALKOXYLATED 2,5-DIHYDROFURAN CYP4F2, CYP4F12, CYP2F1 CHRM2 3062/4885CHRM1 3811/4885CHRM3 3256/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.